# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000310158-18-000034
Filing Date
2018-08-07
Accepted
2018-08-07 16:32:58
Documents
97
Period of Report
2018-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 2Q18 FORM 10-Q (MRK 06.30.2018) | mrk0630201810q.htm | 10-Q | 2882349
2 | EXHIBIT 31.1: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO (MRK 06.30.2018) | exhibit311rule13a-14a15dx1.htm | EX-31.1 | 8674
3 | EXHIBIT 31.2: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO (MRK 06.30.2018) | exhibit312rule13a-14a15dx1.htm | EX-31.2 | 8707
4 | EXHIBIT 32.1: SECTION 1350 CERTIFICATION OF CEO (MRK 06.30.2018) | exhibit321section1350certi.htm | EX-32.1 | 5207
5 | EXHIBIT 32.2: SECTION 1350 CERTIFICATION OF CFO (MRK 06.30.2018) | exhibit322section1350certi.htm | EX-32.2 | 5509
| Complete submission text file | 0000310158-18-000034.txt |  | 18047078

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | mrk-20180630.xml | EX-101.INS | 6169119
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20180630.xsd | EX-101.SCH | 70396
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20180630_cal.xml | EX-101.CAL | 108728
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20180630_def.xml | EX-101.DEF | 417484
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20180630_lab.xml | EX-101.LAB | 899989
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20180630_pre.xml | EX-101.PRE | 586088

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 18998577
SIC: 2834 Pharmaceutical Preparations